These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36563831)

  • 1. First evidence of a serine arginine protein kinase (SRPK) in leishmania braziliensis and its potential as therapeutic target.
    Pimentel DC; Leopoldo JR; Teixeira LF; Barros MVA; de Souza APM; Onofre TS; de Carvalho RL; Machado SA; Messias IG; Pinto CCS; Poleto MD; Diogo MA; Mariotini-Moura C; Bressan GC; Teixeira RR; Fietto JLR; Vasconcellos RS
    Acta Trop; 2023 Feb; 238():106801. PubMed ID: 36563831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the variation in the extracellular concentration of l-arginine in the physiology of Leishmania (Viannia) braziliensis and its susceptibility to some antileishmanial drugs.
    Giraldo M; Upegui YA; Higuita-Castro JL; Gonzalez LA; Gutierrez S; Pulido SA; Robledo SM
    Exp Parasitol; 2022 Nov; 242():108395. PubMed ID: 36179851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antifungal compound butenafine eliminates promastigote and amastigote forms of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Bezerra-Souza A; Yamamoto ES; Laurenti MD; Ribeiro SP; Passero LF
    Parasitol Int; 2016 Dec; 65(6 Pt A):702-707. PubMed ID: 27546158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amastin Knockdown in Leishmania braziliensis Affects Parasite-Macrophage Interaction and Results in Impaired Viability of Intracellular Amastigotes.
    de Paiva RM; Grazielle-Silva V; Cardoso MS; Nakagaki BN; Mendonça-Neto RP; Canavaci AM; Souza Melo N; Martinelli PM; Fernandes AP; daRocha WD; Teixeira SM
    PLoS Pathog; 2015 Dec; 11(12):e1005296. PubMed ID: 26641088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of (-)-epigallocatechin 3-O--gallate in vitro and in vivo in Leishmania braziliensis: involvement of reactive oxygen species as a mechanism of action.
    Inacio JD; Gervazoni L; Canto-Cavalheiro MM; Almeida-Amaral EE
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3093. PubMed ID: 25144225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylases inhibitors as new potential drugs against Leishmania braziliensis, the main causative agent of new world tegumentary leishmaniasis.
    Ângelo de Souza L; Silva E Bastos M; de Melo Agripino J; Souza Onofre T; Apaza Calla LF; Heimburg T; Ghazy E; Bayer T; Ferraz da Silva VH; Dutra Ribeiro P; Licursi de Oliveira L; Costa Bressan G; de Almeida Lamêgo MR; Silva-Júnior A; de Souza Vasconcellos R; Suarez-Fontes AM; Almeida-Silva J; Vannier-Santos MA; Pierce R; Sippl W; Lopes Rangel Fietto J
    Biochem Pharmacol; 2020 Oct; 180():114191. PubMed ID: 32777278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biogenesis of Leishmania-harbouring parasitophorous vacuoles following phagocytosis of the metacyclic promastigote or amastigote stages of the parasites.
    Courret N; Fréhel C; Gouhier N; Pouchelet M; Prina E; Roux P; Antoine JC
    J Cell Sci; 2002 Jun; 115(Pt 11):2303-16. PubMed ID: 12006615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Paradoxical Leishmanicidal Effects of Superoxide Dismutase (SOD)-Mimetic Tempol in
    Oliveira LB; Celes FS; Paiva CN; de Oliveira CI
    Front Cell Infect Microbiol; 2019; 9():237. PubMed ID: 31297344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania braziliensis prostaglandin F
    Alves-Ferreira EVC; Ferreira TR; Walrad P; Kaye PM; Cruz AK
    Parasit Vectors; 2020 Jan; 13(1):9. PubMed ID: 31915065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An effective in vitro and in vivo antileishmanial activity and mechanism of action of 8-hydroxyquinoline against Leishmania species causing visceral and tegumentary leishmaniasis.
    Costa Duarte M; dos Reis Lage LM; Lage DP; Mesquita JT; Salles BC; Lavorato SN; Menezes-Souza D; Roatt BM; Alves RJ; Tavares CA; Tempone AG; Coelho EA
    Vet Parasitol; 2016 Feb; 217():81-8. PubMed ID: 26827866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of four Leishmania vaccine candidates in a mouse model of infection with Leishmania (Viannia) braziliensis, the main causative agent of cutaneous leishmaniasis in the New World.
    Salay G; Dorta ML; Santos NM; Mortara RA; Brodskyn C; Oliveira CI; Barbiéri CL; Rodrigues MM
    Clin Vaccine Immunol; 2007 Sep; 14(9):1173-81. PubMed ID: 17626159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of lipids from Leishmania braziliensis promastigotes and amastigotes in macrophage activation.
    Carfagna IE; Penas FN; Bott E; Lammel EM; Goren NB; Belaunzarán ML; Gimenez G
    Mol Immunol; 2020 Sep; 125():104-114. PubMed ID: 32659595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmanicidal activity of synthetic chalcones in Leishmania (Viannia) braziliensis.
    de Mello TF; Bitencourt HR; Pedroso RB; Aristides SM; Lonardoni MV; Silveira TG
    Exp Parasitol; 2014 Jan; 136():27-34. PubMed ID: 24269198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro leishmanicidal activity of imidazole- or pyrazole-based benzo[g]phthalazine derivatives against Leishmania infantum and Leishmania braziliensis species.
    Sánchez-Moreno M; Gómez-Contreras F; Navarro P; Marín C; Ramírez-Macías I; Olmo F; Sanz AM; Campayo L; Cano C; Yunta MJ
    J Antimicrob Chemother; 2012 Feb; 67(2):387-97. PubMed ID: 22127582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
    Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
    J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro leishmanicidal activities of sesquiterpene lactones from Tithonia diversifolia against Leishmania braziliensis promastigotes and amastigotes.
    de Toledo JS; Ambrósio SR; Borges CH; Manfrim V; Cerri DG; Cruz AK; Da Costa FB
    Molecules; 2014 May; 19(5):6070-9. PubMed ID: 24830711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pterocarpanquinone LQB-118 induces apoptosis in Leishmania (Viannia) braziliensis and controls lesions in infected hamsters.
    Costa L; Pinheiro RO; Dutra PM; Santos RF; Cunha-Júnior EF; Torres-Santos EC; da Silva AJ; Costa PR; Da-Silva SA
    PLoS One; 2014; 9(10):e109672. PubMed ID: 25340550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
    Datta AK; Datta R; Sen B
    Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of the anti-leishmanial activity and toxicity of PK11195.
    Guedes CES; Dias BRS; Petersen ALOA; Cruz KP; Almeida NJ; Andrade DR; Menezes JPB; Borges VM; Veras PST
    Mem Inst Oswaldo Cruz; 2018 Feb; 113(4):e170345. PubMed ID: 29412342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of promastigotes and intracellular amastigotes from distinct Leishmania species to the calpain inhibitor MDL28170.
    de Sousa Araújo PS; de Oliveira SSC; d'Avila-Levy CM; Dos Santos ALS; Branquinha MH
    Parasitol Res; 2018 Jul; 117(7):2085-2094. PubMed ID: 29728827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.